In the exciting field of 3D bioprinting, the prospects for testing new medicines using 3D printed organ tissue are some of the most promising and most fully realized. By 3D printing tissues, pharmaceutical researchers can measure the toxicity levels of drug compounds on 3D printed liver cells, kidney cells, etc., giving them an idea of how the compound will react in a real human body. This potentially reduces the need to test on animal subjects and can bring the drugs to market more quickly.…
The original post Organovo Partners with Johnson & Johnson for 3D Bioprinting Drug Discovery Research appeared first on 3D Printing Industry.